WeVote
Log In

Bill

Bill

HB 5102

Relating to applicability of certain prescription drug insurance laws to health benefit plans and pharmacy benefit managers.

89th Legislature (2025) Introduced by Greg Bonnen

HB 5102 adjusts which prescription drug insurance regulations apply to Texas health plans and pharmacy benefit managers, potentially affecting drug pricing oversight and coverage requirements.

Referred to Insurance
#insurance #commissionerof(v0396) #insurance--health&accident(i0422) #medicine&prescriptiondrugs(s7338) #pharmacybenefitmanagers(s0648)
0
WeVote Research Nonpartisan
Bill Summary · HB 5102

Legislative bill overview

HB 5102 modifies how Texas prescription drug insurance laws apply to health benefit plans and pharmacy benefit managers (PBMs). The bill appears to adjust the regulatory scope or applicability requirements for existing prescription drug insurance statutes to PBMs and health plans operating in Texas. The specific amendments would clarify which entities must comply with certain insurance regulations related to prescription drug coverage.

Why is this important

Prescription drug costs and PBM practices have become increasingly controversial, as these intermediaries significantly influence drug pricing and access. Clarifying regulatory applicability directly affects how insurance plans manage drug coverage, pharmacy networks, and pricing transparency. This could impact prescription costs and coverage availability for Texas residents, depending on whether the bill expands or restricts regulatory requirements.

Potential points of contention

  • Regulatory burden vs. consumer protection: Expanding PBM regulations increases compliance costs but may protect consumers; conversely, narrowing applicability could reduce costs but limit oversight of problematic practices
  • Market competition concerns: Changes to regulatory applicability could affect competition among PBMs and insurers, potentially influencing drug pricing and plan options available to Texans
  • Specificity unknown: The bill's text is not yet publicly detailed, making it unclear whether this expands protections, reduces requirements, or simply clarifies existing law—each scenario creates different stakeholder opposition

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.